Menu

Research

Adoption of high speed rails can aid in growth of India’s EV adoption rate like China

Rail Vikas Nigam Limited (RVNL) IPO Research Note should you subscribe?

Rail Vikas Limited (RVNL) has come up with an IPO at price band of Rs. 17- Rs. 19. RVNL is a wholly owned government entity under the Ministry of Railway....

Metal Scrap Trade Corporation Limited (MSTC) -IPO note: AVOID

Issue Highlights: Metal Scrap Trade Corporation Limited (MSTC) is a Public Sector Undertaking incorporated on 9th September 1964 with headquarters in Kolkata, India. MSTC comes under category-I Mini Ratna owned...
Apollo Hospitals Q2 FY26: Double-Digit Growth Across Healthcare, Digital & Diagnostics as Core Businesses Expand

Sun Pharma Ltd. result update for Q3FY19

Sun Pharmaceutical is 5th in the speciality generic segment globally and one of the top pharmaceutical company in India. With patients spread across 150 countries globally. They have 42 manufacturing...
GK Energy Limited IPO: Assessing Investment Potential in India’s Solar-Powered Agricultural Infrastructure

K.P.I Global Infrastructure Limited IPO Note

KPI Global Infrastructure Limited a subsidiary of the KPI Group is fundamentally involved in the generation and supply of solar power. It has broadened its horizons by extending its operations...

K.P.I Global Infrastructure Ltd. management interaction

Sky is the Limit” – said Mr. Faruk Patel when asked about the future of renewable energy and the company’s latest foray into solar energy market place. KPI Global Infrastructure...
Q2FY19 Results, Cipla Ltd. posted Rs 367 crores net profit

Q2FY19 Results, Cipla Ltd. posted Rs 367 crores net profit

Cipla Ltd is one of the leading Indian pharmaceutical company. It was incorporated in the year 1935. The company primarily focuses on its complex generics business and deepening its product...
Lupin Soars on USFDA Nod for Billion-Dollar Drug

Q2FY19 Results, Lupin Ltd. posted Rs 266 crores net profit

Lupin Ltd is a multinational pharmaceutical company, incorporated in the year 1968. It is the eighth-largest generic pharmaceutical company in terms of revenue globally. The company’s key business areas are...
AstraZeneca Pharma India Q1 2026: Strong Growth and Resilience

Q2FY19 Results, Aurobindo Pharma Ltd. posted Rs 611.40 crores net profit

Aurobindo Pharma Limited is a fully integrated pharmaceutical company, incorporated in the year 1986. The Company manufactures Generic pharmaceutical, Active Pharmaceuticals Ingredients (API), Formulation drugs and speciality products. The companies...
Strategic Consolidation: Emcure to Fully Take Over Zuventus Healthcare

Q2FY19 Results, Sun Pharma posts 218.8 cr net loss

Sun Pharmaceutical Industries is an Indian Pharmaceutical that manufactures and sells pharmaceutical formulations, Active Pharmaceutical Ingredient (API) incorporated in 1983. The company provides formulations in various therapeutic areas such as...
Tata Motors Q2 FY26: Sales Momentum in CVs (94,681 units, +12%), Revenue Growth Modest, Profitability Under Pressure

Tata Motors Ltd. Result update for Q1FY19

Tata Motors is among the world’s leading manufacturers of automobiles. Tata Motors is a $45 billion organization. It is India’s largest and the solely Original Equipment Manufacturer (OEM) offering a...